title: Clinical aspects of antimicrobial prophylaxis for invasive urological procedures.
abstract: The essential value of antimicrobial prophylaxis is to defend the patient undergoing invasive diagnostic procedures or surgery against infectious complications by reducing the bacterial load. Escherichia coli remains the predominant uropathogen (70-80%) isolated in acute community-acquired uncomplicated infections, followed by Staphylococcus saprophyticus (10 to 15%). Klebsiella, Enterobacter, Proteus species, and enterococci infrequently cause uncomplicated cystitis and pyelonephritis. The pathogens traditionally associated with UTI are altering many of their features, particularly because of antimicrobial resistance. Currently, only transurethral resection of prostate and prostate biopsy has been well studied and has high and moderately high levels of evidence in favor of using antibiotic prophylaxis. Other urological interventions have not been well studied. The moderate to low evidence suggests that there is no need for antibiotic prophylaxis in cystoscopy, urodynamic investigations, and extracorporeal shock-wave lithotripsy, whereas the low evidence favors the use of antibiotic prophylaxis for therapeutic ureterorenoscopy and percutaneous nephrolithotomy. The scarce data from studies on transurethral resection of bladder tumors cannot provide a definitive indication for antibiotic prophylaxis for this intervention.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Mirone
authors.forename: Marco
authors.initials: M
authors.lastname: Franco
mesh_terms: D019072:Antibiotic Prophylaxis / Q000379:methods*; D003950:Diagnostic Techniques, Urological / Q000009:adverse effects*; D006801:Humans; D014552:Urinary Tract Infections / Q000209:etiology / Q000517:prevention & control*; D013520:Urologic Surgical Procedures / Q000009:adverse effects*
keywords: Antibiotic prophylaxis,; Drug resistance,; Fosfomycin trometamol; Urological surgery,